Adenosine Stimulates the Migration of Human Endothelial Progenitor Cells. Role ofCXCR4 and MicroRNA-150

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Rolland Turner, Magali ^a   Goretti, Emeline ^a   Bousquenaud, Mélanie ^a   Léonard, Frédérique ^a   Nicolas, Christelle ^a   Zhang, Lu ^a   Maskali, Fatiha ^b   Marie, Pierre Yves ^b   Devaux, Yvan ^a   Wagner, Daniel ^a,c  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b Nancyclotep Experimental Imaging Platform   (France)

^c Centre Hospitalier   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; ADENOSINE A2B RECEPTOR; CHEMOKINE RECEPTOR CXCR4; MICRORNA; MICRORNA 150; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; ENZYME REGULATION; FIBROBLAST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; HUMAN CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RAT; TREATMENT RESPONSE;

ADENOSINE; CELL MOVEMENT; ENDOTHELIAL CELLS; HEK293 CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICRORNAS; MYOCARDIAL INFARCTION; RECEPTORS, CXCR4; REGENERATION; STEM CELLS; TISSUE THERAPY; UP-REGULATION;

RATTUS;

EID: 84872172471     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054135     Document Type: Article

References (42)

1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, et al. (2011) Forecasting the Future of Cardiovascular Disease in the United States. Circulation 123: 933-944.
2. Siddique A, Shantsila E, Lip GY, Varma C, (2010) Endothelial progenitor cells: what use for the cardiologist? J Angiogenes Res 2: 6.
3. Rafii S, Lyden D, (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712.
4. Tongers J, Losordo DW, Landmesser U, (2011) Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 32: 1197-1206.
5. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, et al. (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110: 3300-3305.
6. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, et al. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283: 845-848.
7. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
8. Lapidot T, Dar A, Kollet O, (2005) How do stem cells find their way home? Blood 106: 1901-1910.
9. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, et al. (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97: 1142-1151.
10. Oh BJ, Kim DK, Kim BJ, Yoon KS, Park SG, et al. (2010) Differences in donor CXCR4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells. Biochem Biophys Res Commun 398: 627-633.
11. Tano N, Kim HW, Ashraf M, (2011) microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4. PLoS One 6: e23114.
12. Fredholm BB, Ijzerman AP, Jacobson KA, Linden J, Muller CE, (2011) International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update. Pharmacol Rev 63: 1-34.
13. Ryzhov S, Solenkova NV, Goldstein AE, Lamparter M, Fleenor T, et al. (2008) Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ Res 102: 356-363.
14. Ernens I, Rouy D, Velot E, Devaux Y, Wagner DR, (2006) Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP/PKA/Ca2+ pathway. Circ Res 99: 590-597.
15. Velot E, Haas B, Leonard F, Ernens I, Rolland-Turner M, et al. (2008) Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages. Cardiovasc Res 80: 246-254.
16. Ernens I, Leonard F, Vausort M, Rolland-Turner M, Devaux Y, et al. (2010) Adenosine up-regulates vascular endothelial growth factor in human macrophages. Biochem Biophys Res Commun 392: 351-356.
17. Leonard F, Devaux Y, Vausort M, Ernens I, Rolland-Turner M, et al. (2011) Adenosine modifies the balance between membrane and soluble forms of Flt-1. J Leukoc Biol 90: 199-204.
18. Azuaje F, Leonard F, Rolland-Turner M, Devaux Y, Wagner DR, (2011) Proof-of-principle investigation of an algorithmic model of adenosine-mediated angiogenesis. Theor Biol Med Model 8: 7.
19. Wagner DR, Combes A, McTiernan C, Sanders VJ, Lemster B, et al. (1998) Adenosine inhibits lipopolysaccharide-induced cardiac expression of tumor necrosis factor-alpha. Circ Res 82: 47-56.
20. Wagner DR, Kubota T, Sanders VJ, McTiernan CF, Feldman AM, (1999) Differential regulation of cardiac expression of IL-6 and TNF-alpha by A2- and A3-adenosine receptors. Am J Physiol 276: H2141-2147.
21. Wagner DR, McTiernan C, Sanders VJ, Feldman AM, (1998) Adenosine inhibits lipopolysaccharide-induced secretion of tumor necrosis factor-alpha in the failing human heart. Circulation 97: 521-524.
22. Azuaje FJ, Wang H, Zheng H, Leonard F, Rolland-Turner M, et al. (2011) Predictive integration of gene functional similarity and co-expression defines treatment response of endothelial progenitor cells. BMC Syst Biol 5: 46.
23. Chavakis E, Carmona G, Urbich C, Gottig S, Henschler R, et al. (2008) Phosphatidylinositol-3-Kinase-{gamma} Is Integral to Homing Functions of Progenitor Cells. Circ Res 102: 942-949.
24. Devaux Y, Azuaje F, Vausort M, Yvorra C, Wagner DR, (2010) Integrated protein network and microarray analysis to identify potential biomarkers after myocardial infarction. Funct Integr Genomics 10: 329-337.
25. Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, et al. (2006) An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes. Nucleic Acids Res 34: e87.
26. Goldman S, Raya TE, (1995) Rat infarct model of myocardial infarction and heart failure. J Card Fail 1: 169-177.
27. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, et al. (1979) Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512.
28. Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, et al. (2010) Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation 122: 495-506.
29. Van Belle H, Goossens F, Wynants J, (1987) Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am J Physiol 252: H886-893.
30. Murphree LJ, Sullivan GW, Marshall MA, Linden J, (2005) Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem J 391: 575-580.
31. Ramanathan M, Luo W, Csoka B, Hasko G, Lukashev D, et al. (2009) Differential regulation of HIF-1{alpha} isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists. J Leukoc Biol 86: 681-689.
32. Klaasse EC, Ijzerman AP, de Grip WJ, Beukers MW, (2008) Internalization and desensitization of adenosine receptors. Purinergic Signal 4: 21-37.
33. Richard CL, Tan EY, Blay J, (2006) Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha. Int J Cancer 119: 2044-2053.
34. Montesinos MC, Shaw JP, Yee H, Shamamian P, Cronstein BN, (2004) Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am J Pathol 164: 1887-1892.
35. Yang D, Koupenova M, McCrann DJ, Kopeikina KJ, Kagan HM, et al. (2008) The A2b adenosine receptor protects against vascular injury. Proc Natl Acad Sci U S A 105: 792-796.
36. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J, (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
37. Povsic TJ, Zavodni KL, Kelly FL, Zhu S, Goldschmidt-Clermont PJ, et al. (2007) Circulating progenitor cells can be reliably identified on the basis of aldehyde dehydrogenase activity. J Am Coll Cardiol 50: 2243-2248.
38. Capoccia BJ, Robson DL, Levac KD, Maxwell DJ, Hohm SA, et al. (2009) Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood 113: 5340-5351.
39. Sondergaard CS, Hess DA, Maxwell DJ, Weinheimer C, Rosova I, et al. (2010) Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. J Transl Med 8: 24.
40. Bousquenaud M, Schwartz C, Leonard F, Rolland-Turner M, Wagner D, et al. (2012) Monocyte chemotactic protein 3 is a homing factor for circulating angiogenic cells. Cardiovasc Res 94: 519-525.
41. Fleissner F, Jazbutyte V, Fiedler J, Gupta SK, Yin X, et al. (2010) Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21-Dependent Mechanism. Circ Res 107: 138-143.
42. Zhang Y, Liu D, Chen X, Li J, Li L, et al. (2010) Secreted Monocytic miR-150 Enhances Targeted Endothelial Cell Migration. Molecular Cell 39: 133-144.